UFPT Ufp Technologies Inc

$286.29 -2.10%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

Ufp Technologies Inc (UFPT) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $2.2 billion. Shares last traded at $286.29, 15.5% below their 52-week high. Over the past year the stock is up 40.8%. UFPT trades at a price-to-earnings ratio of 30.67, above the Surgical & Medical Instruments & Apparatus median of 28.18. Net profit margin is 11.4%, above the peer median of -9.3%. Revenue grew 19.5% year over year.

Market Cap

$2.2B

Shares Out

7.7M

EPS (TTM)

$13.79

P/E Ratio

20.76

P/S Ratio

3.51

P/B Ratio

4.80

Dividend / Share

—

Dividend Yield

—

52-Week High

$338.70

52-Week Low

$173.77

Volume

10,305

Avg Vol (3m)

11,247

Performance

-4.69%

-11.33%

+27.49%

+41.65%

YTD

+28.04%

+40.76%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

43.30

SMA (50)

$278.97

SMA (200)

$237.00

Price vs SMA50

+2.62%

Price vs SMA200

+20.80%

ATR (14)

$10.85

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$632M

Net Income

$72M

Gross Margin

28.5%

Operating Margin

15.3%

Net Margin

11.4%

Return on Equity

15.6%

Return on Assets

10.6%

Current Ratio

3.00

Debt / Equity

0.25

Revenue Growth (YoY)

+19.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$4.92	2026-08-06
Q1 2026	$2.24	2026-05-08
FY 2025	$8.75	2026-02-27
FY 2025	$2.11	2026-02-27
Q2 2026	$4.42	2026-08-06
Q1 2026	$2.21	2026-05-08

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

UFPT vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/E vs peers

30.67 / 28.18 med

+9% premium

P/S vs peers

3.51 / 2.94 med

+20% premium

Net margin vs peers

11.4% / -9.3% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.